← The Wire
PBLSNasdaq
Parabilis Medicines, Inc.
Pharmaceutical Preparations · DE · CIK 1657677
Develops stabilized helical peptide therapeutics targeting protein interactions for human diseases
⚡ Elevated coverage
$3.33B
Market cap
$29.19
Last close
+1.4%
1D
+6.0%
5D
557K
Volume
Price · last 13 sessions-7.6%
Jun 10L $25.01 · H $31.60Jun 29
6
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
In the News
⚡ Elevated coverageCoverage (30d): 4 reputable articles · skews – neutral.
MorningstarParabilis Is Now the Largest VC-Backed Biotech IPO19d agoWSJParabilis Medicines Shares Rocket Following Record Biotech IPO19d agoReutersParabilis Medicines targets $2.3 billion valuation in upsized US IPO21d agoReutersParabilis Medicines aims to raise up to $475 million in US IPO26d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance